ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prevention"

  • Abstract Number: 2002 • ACR Convergence 2022

    Do SMS and Email Reminders Increase the Rate of Seasonal Influenza Vaccination in RA Patients Treated with Biologics: A Nested Randomized Controlled Trial Within the ART Registry?

    Raphaèle Seror1, Gabriel Baron2, Sylvie Miconnet3, Rakiba Belkhir3, Martin Soubrier4, pascale thevenot5, andre basch6, Marie Truchetet7, Pascal Claudepierre8, Emmanuelle Dernis9, Hubert Marotte10, René-Marc Flipo11, Olivier Brocq12, Jacques Morel13, CARINE SALLIOT14, Bruno Fautrel15, Alain Saraux16, CHARLES LESKE17, Naïma Hamamouche18, Thierry schaeverbeke19, Xavier Mariette20, Adeline Ruyssen-Witrand21 and Philippe Ravaud22, 1University Hospital Paris-Saclay, Le Kremlin Bicêtre, France, 2AP-HP Hôtel Dieu Hospital, Université Paris Descartes, Paris, France, 3Rheumatology departement, Bicêtre, Paris-Saclay university, Le Kremlin Bicêtre, France, 4Gabriel-Montpied Hospital, Clermont-Ferrand, France, 5French Society of rheumatology, Paris, France, 6Infirmerie Protestante de Lyon, Caluire-et-Cuire, France, 7Bordeaux University Hospital, Bordeaux, France, 8Paris Est Creteil University, Creteil, France, 9LE MANS general hospital, LE MANS, France, 10INSERM 1059, Saint-Etienne, France, 11CHU Lille, Boulogne-Billancourt, France, 12Rheumatology- CH Princesse Grace, Monaco, Monaco, 13University and CHU Montpellier, Montpellier, France, 14CHR orleans, Orleans, France, 15Sorbonne University Paris, France and Pierre Louis Institute of Epidemiology and Public Health, Paris, France, Paris, France, 16CHU Brest, Brest, France, 17Hospital, Cholet, France, 18e-health Services Sanoïa, Gémenos, France, 19CHU de Bordeaux, Bordeaux, France, 20Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 21CHU de Toulouse, Toulouse, France, 22Université Paris Cité, Hôtel-Dieu, Paris, France

    Background/Purpose: In patients treated with biologics, vaccination against influenza is recommended. However, vaccination coverage remains very low. The use of automatic digital reminders is an…
  • Abstract Number: 0084 • ACR Convergence 2022

    Facilitators and Barriers of Vaccine Uptake in Patients with Chronic Inflammatory Rheumatic Disease: A Scoping Review

    Silke Neusser1, Anja Neumann1, Christian Speckemeier1, Pauline zur NIeden1, Sarah Schlierenkamp1, Anke Walendzik1, Ute Karbach2, Ioana Andreica3, Kristina Vaupel4, Xenofon Baraliakos5 and Uta Kiltz4, 1Essener Forschungsinstitut für Medizinmanagement, Essen, Germany, 2Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Cologne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) remain underrepresented in receiving vaccinations despite being disproportionately affected by infectious complications. The aim of our study…
  • Abstract Number: 1065 • ACR Convergence 2022

    Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biololgical Diagnosis of Disease

    Rebecca Ross1, Emily Clarke1, Will Merchant1, Panji Mulipa1, Natalia Riobo-DelGaldo1 and Francesco Del Galdo2, 1University of Leeds, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health and NIHR Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The VEDOSS study has recently indicated that more than 50% of patients affected by Raynaud’s phenomenon (RP) and specific SSc anti-nuclear antibodies (ANA) and/or…
  • Abstract Number: 2052 • ACR Convergence 2022

    Vaccine Uptake in Women with Systemic Lupus Erythematosus (SLE) in a Large Urban Teaching Hospital Serving a High-Risk Population

    J. Patricia Dhar1, Forsythe Hannah2, Louis Saravolatz3 and Susanna Szpunar4, 1Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI, 2Michigan Department of Human and Health Services, Lansing, MI, 3Ascension St John Hospital and Medical Center, Wayne State University School of Medicine (affiliate), Grosse Pointe Woods, MI, 4Ascension St. John Hospital, Grosse Pointe Woods, MI

    Background/Purpose: Infections are a major cause of morbidity & mortality in patients with systemic lupus erythematosus (SLE), including vaccine-preventable infections. SLE patients are considered to…
  • Abstract Number: 0114 • ACR Convergence 2021

    The Safety Profile of SARS-CoV-2 Vaccines Among Patients with Immune-Mediated Rheumatic Diseases

    Jose A Gomez-Puerta1, Núria Sapena2, Juan C Sarmiento-Monroy3, Ana Belén Azuaga1, Virginia Ruiz-Esquide2, Beatriz Frade-Sosa2, Marta Bassas2, Rosa Morlà2, Andrés Ponce2, Juan D Cañete1, Julio Ramirez2, Anna Villella4, Antoni Trilla4 and Raimon Sanmarti5, 1Rheumatology Department, Hospital Clinic, Barcelona, Spain, 2Rheumatology Department, Hospital Clínic, Barcelona, Spain, 3Hospital Clinic Barcelona, Barcelona, Spain, 4Department of Preventive Medicine and Epidemiology, Hospital Clínic, Barcelona, Spain, 5Hospital Clínic de Barcelona, Barcelona, Spain

    Background/Purpose: The best strategy for the prevention of SARS-CoV-2 infection is vaccination. Both mRNA and vector vaccines have demonstrated a satisfactory safety profile in general…
  • Abstract Number: 0116 • ACR Convergence 2021

    COVID-19 mRNA Vaccine Side Effects Among Individuals with Rheumatic Disease

    Kaleb Michaud1, Adam Cornish2, Alison Freifeld1, Patricia Katz3 and Kristin Wipfler2, 1University of Nebraska Medical Center, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 3University of California San Francisco, San Francisco, CA

    Background/Purpose: Over 135 million Americans were fully vaccinated to COVID-19 by June 2021, yet there was a paucity of data on side effects for those…
  • Abstract Number: 0141 • ACR Convergence 2021

    Who Gets Influenza Vaccinations Prior to and After a Diagnosis of RA? Results from the Canadian Early Arthritis Cohort (CATCH)

    Viviane Ta1, Orit Schieir2, Marie-France Valois1, Ines Colmegna3, Carol Hitchon4, Louis Bessette5, Glen Hazlewood6, Carter Thorne7, Janet Pope8, Gilles Boire9, Diane Tin10, Edward Keystone11, Vivian Bykerk12, Susan Bartlett1 and CATCH Investigators13, 1McGill University, Montréal, QC, Canada, 2Canadian Early Arthritis Cohort Study, Montréal, QC, Canada, 3The Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5Centre de l'Ostoporose et de Rhumatologie de Qubec, Québec City, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7Southlake Regional Health Centre, Newmarket, ON, Canada, 8University of Western Ontario, London, ON, Canada, 9Universite de Sherbrooke, Sherbrooke, QC, Canada, 10The Arthritis Program Research Group, Newmarket, ON, Canada, 11Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 12Hospital for Special Surgery, New York, NY, 13Canadian Early Arthritis Cohort Investigators, Toronto, ON, Canada

    Background/Purpose: Annual influenza vaccination is recommended for adults with RA, but remains low in established RA. We examined influenza vaccination coverage in the year prior…
  • Abstract Number: 0461 • ACR Convergence 2021

    Plasmablast-derived Autoantibodies from Individuals At-risk for RA That Target RA-relevant Antigens Are Polyreactive with Arthritogenic Bacteria

    Meagan Chriswell1, Jennifer Seifert2, Michelle Bloom3, Cliff Rims4, Marie Feser5, Kevin Deane6, Jill Norris7, Eddie James8, Jane Buckner9, William Robinson10, V. Michael Holers11 and Kristine Kuhn12, 1UC Denver SOM, Denver, CO, 2University of Colorado School of Medicine, Littleton, CO, 3Stanford University, Redwood City, CA, 4Benaroya Research Institute, Seattle, WA, 5University of Colorado Denver, Aurora, CO, 6University of Colorado Denver, Denver, CO, 7Colorado School of Public Health, Aurora, CO, 8Benaroya Research Institute at Virginia Mason, Monroe, WA, 9Benaroya Research Institute at Virginia Mason, Seattle, WA, 10Stanford University, Palo Alto, CA, 11University of Colorado, Denver, CO, 12University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Circulating autoantibodies like ACPA frequently develop years before symptoms of RA, during which the individual is at-risk for disease. Several lines of evidence suggest…
  • Abstract Number: 0876 • ACR Convergence 2021

    Antibody Response in Patients with Systemic Lupus Erythematosus After a Two-dose Regimen with SARS-CoV-2 Vaccines (Preliminary Results)

    Emilie Stavnsbjerg Larsen1, Anna Christine Nilsson2, Ulrik Stenz Justesen1, Anne Voss3 and Isik Somuncu Johansen4, 1Odense University Hospital, Odense C, Denmark, 2Odense Universitets Hospital, Odense C, Denmark, 3Department of Rheumatology, Odense University Hospital, Odense C, Denmark, 4Odense University Hospital, Odense, Denmark

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) often receive immunosuppressive treatment for many years, resulting in higher risk of infections, including COVID-19, and infections may…
  • Abstract Number: 0957 • ACR Convergence 2021

    Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial

    Jill Hahn1, Nancy Cook2, Erik Alexander3, Sonia Friedman3, Vadim Bubes3, Joseph Walter3, Gregory Kotler3, I-Min Lee3, JoAnn Manson3 and Karen Costenbader4, 1Harvard T.H. Chan School of Public Health, Boston, MA, 2Brigham and Womens' Hospital, Boston, MA, 3Brigham and Women's Hospital/ Harvard Medical School, Boston, MA, 4Brigham and Women's Hospital, Belmont, MA

    Background/Purpose: In observational studies, vitamin D has been inconsistently associated with reduced risk of several autoimmune diseases, and a large randomized, controlled trial has been…
  • Abstract Number: 1077 • ACR Convergence 2021

    Effectiveness of Non-Pharmacological Interventions to Promote Work Participation of People with Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Regression Analysis

    Maarten Butink1, Casper Webers2, Suzanne Verstappen3, Robin Christensen4, Louise Falzon5, Johannes Bijlsma6, Gerd Burmester7 and Annelies Boonen2, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+); Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht, Limburg, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands, 3School of Social Sciences, The University of Manchester, Manchester, United Kingdom, 4Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen & Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Copenhagen, Denmark, 5Center for Personalized Health, Northwell Health, New York City, NY, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 7Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Despite improvements in the treatment of rheumatic and musculoskeletal diseases (RMDs), reduced work participation persists when compared to the general population. A Task Force…
  • Abstract Number: 1139 • ACR Convergence 2021

    Fracture Liaison Service Outcomes at a Southern California County Hospital Highlights Need for Health System Improvements

    Muntarin Karim1, lorien ahn2, Jordan Thompson1, Christina Downey3, Lorena Salto4 and Karina Torralba5, 1Loma Linda University, Redlands, CA, 2loma linda university medical center, Loma Linda, CA, 3Loma Linda University Medical Center, Redlands, CA, 4Loma Linda University Health, Loma Linda, CA, 5Division of Rheumatology, Department of Medicine, Loma Linda University Healthcare, Loma Linda, CA

    Background/Purpose: Osteoporosis causes significant morbidity and mortality in the elderly. Despite the benefits of treatment, < 25% of elderly patients who fracture receive treatment. A…
  • Abstract Number: 1554 • ACR Convergence 2021

    COVID-19 Vaccine Hesitancy Among Patients with Rheumatic and Other Diseases

    Valeria Valerio1, Emmanouil Rampakakis2, Marie Hudson3, Sasha Bernatsky3, Elizabeth M. Hazel3 and Ines Colmegna4, 1Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 2JSS Medical Research, Montréal, QC, Canada, 3McGill University, Montréal, QC, Canada, 4The Research Institute of the McGill University Health Centre, Montréal, QC, Canada

    Background/Purpose: Vaccination is fundamental to reduce COVID-19 risk and its complications. Vaccine hesitancy is a threat to COVID-19 vaccination uptake. We assessed the frequency of…
  • Abstract Number: 1557 • ACR Convergence 2021

    Immunogenicity and Safety of an Inactivated Virus Vaccine Against SARS-CoV-2 in Patients with Autoimmune Rheumatic Diseases

    Ana Medeiros-Ribeiro1, Nadia Aikawa1, Carla Gonçalves Schahin Saad1, Emily Figueiredo Vieira Neves Yuki1, Tatiana do Nascimento Pedrosa1, Solange Fusco1, Priscila Rojo1, Rosa Pereira1, Samuel Shinjo1, Danieli Andrade1, Percival Sampaio-Barros1, Carolina Ribeiro1, Giordano Deveza1, Victor Adriano de Oliveira Martins1, Clovis Artur Silva1, Marta Lopes1, Alberto Duarte1, Leila Antonangelo1, Ester Sabino1, Esper Kallas1, Sandra Gofinet Pasoto2 and Eloisa Bonfá1, 1Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Hospital das Clinicas de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Brazil is among the countries with the highest numbers of confirmed cases and deaths by COVID-19. CoronaVac (SARS-CoV-2 inactivated vaccine) has been largely used…
  • Abstract Number: 1616 • ACR Convergence 2021

    Acceptability of COVID-19 Vaccine Among Pediatric Rheumatology Patients in California’s Central Valley

    Sukesh Sukumaran1, Reshma Patel2 and Deepika Singh3, 1Valley Children's Healthcare, Madera, CA, 2Valley Children's Hospital, Madera, CA, 3Valley Children Healthcare, Madera, CA

    Background/Purpose: The U.S. FDA has expanded the emergency use authorization of the COVID-19 vaccine to include children >12 years of age. Gaining an understanding of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology